These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10704057

  • 1. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
    El-Shazly A, Ishikawa T.
    Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
    [Abstract] [Full Text] [Related]

  • 2. Novel association of the src family kinases, hck and c-fgr, with CCR3 receptor stimulation: A possible mechanism for eotaxin-induced human eosinophil chemotaxis.
    El-Shazly A, Yamaguchi N, Masuyama K, Suda T, Ishikawa T.
    Biochem Biophys Res Commun; 1999 Oct 14; 264(1):163-70. PubMed ID: 10527858
    [Abstract] [Full Text] [Related]

  • 3. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J, Höchstetter R, Kimmig D, Kapp A.
    Eur J Immunol; 1996 Aug 14; 26(8):1919-25. PubMed ID: 8765040
    [Abstract] [Full Text] [Related]

  • 4. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
    El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T.
    Int Arch Allergy Immunol; 1998 Sep 14; 117 Suppl 1():55-8. PubMed ID: 9758899
    [Abstract] [Full Text] [Related]

  • 5. Cloning and characterization of the guinea pig eosinophil eotaxin receptor, C-C chemokine receptor-3: blockade using a monoclonal antibody in vivo.
    Sabroe I, Conroy DM, Gerard NP, Li Y, Collins PD, Post TW, Jose PJ, Williams TJ, Gerard CJ, Ponath PD.
    J Immunol; 1998 Dec 01; 161(11):6139-47. PubMed ID: 9834099
    [Abstract] [Full Text] [Related]

  • 6. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J, Petering H, Höchstetter R, Kimmig D, Wells TN, Kapp A, Proudfoot AE.
    Eur J Immunol; 1997 Nov 01; 27(11):2892-8. PubMed ID: 9394815
    [Abstract] [Full Text] [Related]

  • 7. Modulation of normal human eosinophil chemotaxis in vitro by herbimycin A, erbstatin and pervanadate.
    El-Shazly A, Masuyama K, Samejima Y, Eura M, Ishikawa T.
    Int Arch Allergy Immunol; 1998 Sep 01; 117 Suppl 1():10-3. PubMed ID: 9758889
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3.
    Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, Lenaerts JP, Detheux M, Parmentier M, De Meester I, Scharpé S, Van Damme J.
    J Immunol; 1999 Apr 15; 162(8):4903-9. PubMed ID: 10202035
    [Abstract] [Full Text] [Related]

  • 10. Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system.
    Ferland C, Guilbert M, Davoine F, Flamand N, Chakir J, Laviolette M.
    J Leukoc Biol; 2001 May 15; 69(5):772-8. PubMed ID: 11358986
    [Abstract] [Full Text] [Related]

  • 11. Chemokines induce eosinophil degranulation through CCR-3.
    Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K.
    J Allergy Clin Immunol; 2000 Sep 15; 106(3):507-13. PubMed ID: 10984371
    [Abstract] [Full Text] [Related]

  • 12. A novel, selective, and orally available antagonist for CC chemokine receptor 3.
    Morokata T, Suzuki K, Masunaga Y, Taguchi K, Morihira K, Sato I, Fujii M, Takizawa S, Torii Y, Yamamoto N, Kaneko M, Yamada T, Takahashi K, Shimizu Y.
    J Pharmacol Exp Ther; 2006 Apr 15; 317(1):244-50. PubMed ID: 16339911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME, Ownbey R, Mehlhop PD, Loiselle PM, van de Rijn M, Bonventre JV, Oettgen HC, Leder P, Luster AD.
    Mol Med; 1996 May 15; 2(3):334-48. PubMed ID: 8784786
    [Abstract] [Full Text] [Related]

  • 16. Eotaxin is a potent chemotaxin for human basophils.
    Yamada H, Hirai K, Miyamasu M, Iikura M, Misaki Y, Shoji S, Takaishi T, Kasahara T, Morita Y, Ito K.
    Biochem Biophys Res Commun; 1997 Feb 13; 231(2):365-8. PubMed ID: 9070280
    [Abstract] [Full Text] [Related]

  • 17. Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes.
    Forssmann U, Uguccioni M, Loetscher P, Dahinden CA, Langen H, Thelen M, Baggiolini M.
    J Exp Med; 1997 Jun 16; 185(12):2171-6. PubMed ID: 9182688
    [Abstract] [Full Text] [Related]

  • 18. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep 16; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of CCL11, CCL24, and CCL26-induced degranulation in HL-60 eosinophilic cells by specific inhibitors of MEK1/MEK2, p38 MAP kinase, and PI 3-kinase.
    Badewa AP, Heiman AS.
    Immunopharmacol Immunotoxicol; 2003 May 16; 25(2):145-57. PubMed ID: 12784909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.